Stellus Capital Investment (SCM) Expected to Announce Quarterly Earnings on Monday

Stellus Capital Investment (NYSE:SCM) is anticipated to issue its Q2 2026 results after the market closes on Monday, August 10th. Analysts expect the company to post earnings of $0.26 per share and revenue of $24.3750 million for the quarter. Parties are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Tuesday, August 11, 2026 at 11:00 AM ET.

Stellus Capital Investment (NYSE:SCM) last announced its earnings results on Monday, May 11th. The investment management company reported $0.27 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.27. The firm had revenue of $17.45 million during the quarter, compared to analyst estimates of $24.80 million. Stellus Capital Investment had a return on equity of 9.69% and a net margin of 23.59%. On average, analysts expect Stellus Capital Investment to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Stellus Capital Investment Trading Down 0.1%

SCM opened at $7.49 on Monday. The company has a quick ratio of 0.04, a current ratio of 0.04 and a debt-to-equity ratio of 1.05. Stellus Capital Investment has a 52 week low of $6.83 and a 52 week high of $15.04. The stock has a market cap of $216.95 million, a PE ratio of 9.14 and a beta of 0.65. The business has a 50 day moving average of $8.30 and a 200-day moving average of $9.65.

Stellus Capital Investment Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th will be issued a $0.0833 dividend. The ex-dividend date is Wednesday, September 30th. This represents a c) dividend on an annualized basis and a yield of 13.3%. Stellus Capital Investment’s dividend payout ratio is 121.95%.

Analyst Ratings Changes

Several equities analysts have commented on the company. LADENBURG THALM/SH SH lowered their price objective on Stellus Capital Investment from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Wednesday, May 13th. Keefe, Bruyette & Woods reduced their target price on shares of Stellus Capital Investment from $9.00 to $8.00 and set a “market perform” rating on the stock in a research report on Monday, July 20th. Weiss Ratings lowered shares of Stellus Capital Investment from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday, July 28th. Zacks Research raised shares of Stellus Capital Investment from a “strong sell” rating to a “hold” rating in a research report on Friday, May 15th. Finally, Wall Street Zen raised shares of Stellus Capital Investment from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $9.50.

Insiders Place Their Bets

In related news, Director J Tim Arnoult acquired 9,000 shares of Stellus Capital Investment stock in a transaction that occurred on Tuesday, May 19th. The stock was bought at an average price of $9.05 per share, with a total value of $81,450.00. Following the transaction, the director directly owned 50,869 shares in the company, valued at approximately $460,364.45. This represents a 21.50% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last three months, insiders purchased 10,700 shares of company stock worth $96,523. 4.24% of the stock is owned by company insiders.

Institutional Investors Weigh In On Stellus Capital Investment

A number of institutional investors have recently modified their holdings of SCM. Corient Private Wealth LLC increased its holdings in shares of Stellus Capital Investment by 2.6% during the fourth quarter. Corient Private Wealth LLC now owns 281,166 shares of the investment management company’s stock valued at $3,565,000 after acquiring an additional 7,066 shares in the last quarter. Virtus Investment Advisers LLC boosted its stake in Stellus Capital Investment by 3.0% in the 4th quarter. Virtus Investment Advisers LLC now owns 60,048 shares of the investment management company’s stock worth $761,000 after purchasing an additional 1,754 shares in the last quarter. Kestra Advisory Services LLC bought a new position in Stellus Capital Investment in the 4th quarter worth about $62,000. Inspire Advisors LLC grew its position in Stellus Capital Investment by 1.4% during the 4th quarter. Inspire Advisors LLC now owns 107,787 shares of the investment management company’s stock valued at $1,367,000 after purchasing an additional 1,525 shares during the last quarter. Finally, Advisors Asset Management Inc. grew its position in Stellus Capital Investment by 26.8% during the 4th quarter. Advisors Asset Management Inc. now owns 183,055 shares of the investment management company’s stock valued at $2,321,000 after purchasing an additional 38,733 shares during the last quarter. 13.22% of the stock is owned by hedge funds and other institutional investors.

Stellus Capital Investment Company Profile

Stellus Capital Investment Corporation (NYSE: SCM) is a closed-end, externally managed business development company that provides debt and equity financing to middle market companies in the United States. As an investment vehicle specializing in private credit, Stellus focuses on originating and structuring senior secured loans, unitranche facilities, mezzanine debt, and equity co-investments tailored to the unique needs of growing businesses. Its flexible capital solutions are designed to support acquisitions, recapitalizations, growth initiatives, and balance sheet refinancings.

Operating under an evergreen structure, Stellus Capital Investment partners with a diverse group of portfolio companies across industries such as manufacturing, healthcare, business services, and specialty finance.